Cita APA

Londoño, M., Riveiro Barciela, M. d. M., Ahumada, A., Muñoz-Gómez, R., Roget, M., & Devesa-Medina, M. J. (2019). Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in spanish clinical practice – Vie-KinD study.

Citación estilo Chicago

Londoño, María-Carlota, Maria del Mar Riveiro Barciela, Adriana Ahumada, Raquel Muñoz-Gómez, Mercé Roget, y María J. Devesa-Medina. Effectiveness, Safety/tolerability of OBV/PTV/r ± DSV in Patients With HCV Genotype 1 or 4 With/without HIV-1 Co-infection, Chronic Kidney Disease (CKD) Stage IIIb-V and Dialysis in Spanish Clinical Practice – Vie-KinD Study. 2019.

Cita MLA

Londoño, María-Carlota, et al. Effectiveness, Safety/tolerability of OBV/PTV/r ± DSV in Patients With HCV Genotype 1 or 4 With/without HIV-1 Co-infection, Chronic Kidney Disease (CKD) Stage IIIb-V and Dialysis in Spanish Clinical Practice – Vie-KinD Study. 2019.